DCGI Approves Covaxin Clinical Trial On 2-18 Year Age Group | OTV News

3 years ago
#DCGI #Covaxin #BharatBiotech #Covid19 #CovidVaccine #OTVNews

Following careful examination, the Drugs Controller General of India (DCGI) on Wednesday accepted the recommendation of Subject Expert Committee (SEC) and accorded permission to conduct the Phase II/III clinical trial of Covid-19 vaccine - Covaxin in the age group 2 to 18 years, to its manufacturer Bharat Biotech Ltd.
--------------------------------------------------------------------------------------------------------
OdishaTV is Odisha's no 1 News Channel. OTV being the first private satellite TV channel in Odisha carries the onus of charting a course that behoves its pioneering efforts.
Accordingly its charter objectives are FREE, FAIR and UNBIASED. OTV delivers reliable information across all platforms: TV, Internet and Mobile.

Stay tuned for all the breaking news !

Visit Our Website https://odishatv.in/
Android App: bit.ly/OTVAndroidApp
iOS App: http://bit.ly/OTViOSApp
Watch Live: http://live.odishatv.in/
YouTube: https://goo.gl/Ehz6OP
Facebook: https://www.facebook.com/otvnews
OTV English Facebook : https://www.facebook.com/otvenglish
Telegram @otvtelegram @otvkhabar
Twitter: https://twitter.com/otvnews
Instagram: https://www.instagram.com/otvnews/


#OTVNews #OdishaTV

Recommended